Lates News

Sanofi (SNY.O) unveiled its Shanghai Foreign-Funded R&D Innovation Center, and signed a cooperation agreement with Huashan Hospital Affiliated to Fudan University for a "Center of Excellence in Translational Research." In 2025, Sanofi's revenue reached 46.7 billion euros, with China being Sanofi's second-largest market globally. According to the plan, the center will become Sanofi's largest translational medicine research center in China, bringing together global R&D forces to advance innovative drug development in key areas such as immunology, chronic diseases, oncology, and rare diseases. (Yicai)